Medical News

RSS

Agilent Technologies launhces handheld FTIR spectrometer

Agilent Technologies Inc. today introduced a next-generation mobile spectroscopy product that is ideal for on-site testing in a broad range of applications, including advanced materials, art, historical objects, geology, agriculture, composites, coatings and polymers.

4 Mar 2014

Study shows older moderate drinkers who binge drink may have greater mortality

Numerous studies have highlighted the purported association between moderate drinking and reduced mortality. However, these analyses have focused overwhelmingly on average consumption, a measure that masks diverse, underlying drinking patterns such as weekend heavy episodic or binge drinking.

4 Mar 2014

Medtronic, Aetna team up to help insured members with uncontrolled type 2 diabetes

Beginning this month, Aetna and Medtronic, Inc. will work with doctors in a new program to reach up to 300 fully insured members with uncontrolled type 2 diabetes who may improve their health using insulin pump therapy.

From Medtronic 4 Mar 2014

UT Southwestern Medical Center opens new Texas Institute for Brain Injury and Repair

UT Southwestern Medical Center today launched the new Texas Institute for Brain Injury and Repair, a state-funded initiative to promote innovative research and education, with the goals of accelerating translation into better diagnosis and revolutionizing care for millions of people who suffer brain injuries each year.

4 Mar 2014

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and twelve months ended December 31, 2013.

4 Mar 2014

Doctors devise new way to treat atrial fibrillation

Doctors in the U.S. and Japan have devised a way to treat atrial fibrillation by adding a little alcohol to minimally invasive therapies that target a cluster of misbehaving nerves known to trigger arrhythmia. In the most recent Journal of the American College of Cardiology (online before print), the researchers say the new therapy may dull or stop the transmission of electrical impulses that cause atrial fibrillation.

4 Mar 2014

AbbVie's PEARL-III study meets primary, secondary endpoints in patients with chronic GT1b HCV infection

The first detailed results from AbbVie's pivotal phase III study, PEARL-III, were presented today as part of the 21st Conference on Retroviruses and Opportunistic Infections (CROI) press conference and will also be presented as a late-breaker at the conference on March 4.

4 Mar 2014

Angry outbursts increase heart attack risk

Call it what you will - getting red in the face, hot under the collar, losing your cool, blowing your top - we all experience anger. And while we know that anger is a normal, sometimes even beneficial emotion, we're also aware of the often harmful connection between anger and health. New research from Beth Israel Deaconess Medical shows an even more compelling reason to think about getting anger in check - a nearly fivefold increase in risk for heart attack in the two hours following outbursts of anger.

4 Mar 2014

ACD/Labs launches ACD/Spectrus Platform at PITTCON 2014

ACD/Labs, a leading cheminformatics company, announced today to PITTCON 2014 the new release of their ACD/Spectrus Platform that enables organizations to apply chemical context to their spectroscopy, spectrometry, and chromatography content.

4 Mar 2014

Clinton papers offer window into failed health reform effort

Some of the 4,000 pages of previously confidential Clinton administration documents, released Friday by the National Archives, chronicle Hillary Clinton's efforts to overhaul the health system.

4 Mar 2014

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, $150,000,000 of shares of its common stock in an underwritten public offering.

4 Mar 2014

Experts recommend several steps to improve care for prisoners

The very premise of prison invites members of society to think of the people there as walled-off and removed. But more than 95 percent of prisoners will return to the community, often carrying significant health burdens and associated costs with them. In an article in the March issue of the journal Health Affairs, several experts who participated in a scientific workshop convened by the National Research Council and the Institute of Medicine recommend several steps and ideas consistent with health reform to improve care for prisoners while they are incarcerated and after they return to society.

4 Mar 2014

Proactive health measures are the secret to health and happiness

The secret to health and happiness just may lie in the simple things, like spending time outdoors, according to a new survey by Traditional Medicinals, the nation's leading wellness tea company.

4 Mar 2014

Majority of Medicare home health beneficiaries are old, poor and more likely to be women

New analyses completed by Avalere Health and Dobson DaVanzo & Associates released today by the Partnership for Quality Home Healthcare find that the majority of Medicare home health beneficiaries and caregivers, both skilled and informal, are women and that Medicare home health beneficiaries are among the most vulnerable of all Medicare beneficiaries.

4 Mar 2014

New research uncovers abnormal molecular signaling pathways for kidney failure

Prevention and reversal of chronic kidney disease is an urgent public health need. The disease affects 1 in 10 Americans, is debilitating and deadly, and existing drugs, at best, offer only mild delay in progression to end-stage kidney failure.

4 Mar 2014

Arrowhead receives approval to initiate Phase 2a clinical trial of ARC-520 for chronic HBV infection

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received regulatory approval to begin a Phase 2a clinical trial of ARC-520, its RNAi-based drug candidate for the treatment of chronic hepatitis B virus (HBV) infection.

4 Mar 2014

New theory on the causation of type 2 diabetes

At 85, Nobel laureate James D. Watson, the co-discoverer of the double-helix structure of DNA, continues to advance intriguing scientific ideas. His latest, a hypothesis on the causation of type 2 diabetes, is to appear 7 pm Thursday US time in the online pages of The Lancet, the prestigious British medical journal.

4 Mar 2014

Intra-Cellular Therapies initiates Phase I/II clinical trial to evaluate pharmacokinetics in patients with dementia

Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the initiation of ITI-007-200, a Phase I/II clinical trial designed to evaluate the safety, tolerability and pharmacokinetics of low doses of its lead drug candidate, ITI-007, in healthy geriatric subjects and in patients with dementia, including Alzheimer's disease.

4 Mar 2014

Microgravity may suppress tumors, study reveals

In space, things don't always behave the way we expect them to. In the case of cancer, researchers have found that this is a good thing: some tumors seem to be much less aggressive in the microgravity environment of space compared to their behavior on Earth. This observation, reported in research published in February by the FASEB Journal, could help scientists understand the mechanism involved and develop drugs targeting tumors that don't respond to current treatments. This work is the latest in a large body of evidence on how space exploration benefits those of us on Earth.

4 Mar 2014

Global Customer Support team of Wolters Kluwer Health receives NorthFace ScoreBoard award from Omega

Wolters Kluwer Health is pleased to announce that its Global Customer Support team for the Ovid and LWW Journals product lines has received the NorthFace ScoreBoard AwardSM from Omega Management Group Corp for excellence in service during 2013.

4 Mar 2014

Medical News

Agilent Technologies launhces handheld FTIR spectrometer

Study shows older moderate drinkers who binge drink may have greater mortality

Medtronic, Aetna team up to help insured members with uncontrolled type 2 diabetes

UT Southwestern Medical Center opens new Texas Institute for Brain Injury and Repair

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

Doctors devise new way to treat atrial fibrillation

AbbVie's PEARL-III study meets primary, secondary endpoints in patients with chronic GT1b HCV infection

Angry outbursts increase heart attack risk

ACD/Labs launches ACD/Spectrus Platform at PITTCON 2014

Clinton papers offer window into failed health reform effort

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

Experts recommend several steps to improve care for prisoners

Proactive health measures are the secret to health and happiness

Majority of Medicare home health beneficiaries are old, poor and more likely to be women

New research uncovers abnormal molecular signaling pathways for kidney failure

Arrowhead receives approval to initiate Phase 2a clinical trial of ARC-520 for chronic HBV infection

New theory on the causation of type 2 diabetes

Intra-Cellular Therapies initiates Phase I/II clinical trial to evaluate pharmacokinetics in patients with dementia

Microgravity may suppress tumors, study reveals

Global Customer Support team of Wolters Kluwer Health receives NorthFace ScoreBoard award from Omega

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News